NZ599097A - Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer - Google Patents
Chimeric antibodies specific for cd151 and use thereof in the treatment of cancerInfo
- Publication number
- NZ599097A NZ599097A NZ599097A NZ59909710A NZ599097A NZ 599097 A NZ599097 A NZ 599097A NZ 599097 A NZ599097 A NZ 599097A NZ 59909710 A NZ59909710 A NZ 59909710A NZ 599097 A NZ599097 A NZ 599097A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cancer
- treatment
- antibodies specific
- chimeric antibodies
- binds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
599097 Disclosed is a chimeric antibody that binds to CD151 comprising a light chain and a heavy chain sequences DIVLSQSPASLALSLGQRATISCRASASVEYYGTSLMHWYQQKPGQPPKLLIYEASNVESGVPARFSGSGSGTDFSLNIHPVEEDDLAIYFCQQSRKAPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC and EVKLVESGGGLVQPGGSLKLSCAASGFTFSTYTMSWVRQTPEKRLEWVAYISSGGGTTYYPDTVKGRFTISRDNARNTLYLQMNSLKSEDTAMYYCATPRIGTGFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNST YRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK, respectively.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09305964A EP2308897A1 (en) | 2009-10-09 | 2009-10-09 | Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
US26602009P | 2009-12-02 | 2009-12-02 | |
PCT/EP2010/065085 WO2011042534A1 (en) | 2009-10-09 | 2010-10-08 | Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ599097A true NZ599097A (en) | 2014-03-28 |
Family
ID=41682879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ599097A NZ599097A (en) | 2009-10-09 | 2010-10-08 | Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer |
Country Status (19)
Country | Link |
---|---|
US (1) | US20120275997A1 (en) |
EP (2) | EP2308897A1 (en) |
JP (1) | JP2013507114A (en) |
KR (1) | KR20120094474A (en) |
CN (1) | CN102597004A (en) |
AR (1) | AR078572A1 (en) |
AU (1) | AU2010305360A1 (en) |
BR (1) | BR112012008266A2 (en) |
CA (1) | CA2775634A1 (en) |
IL (1) | IL219034A0 (en) |
IN (1) | IN2012DN02696A (en) |
MA (1) | MA33668B1 (en) |
MX (1) | MX2012004059A (en) |
NZ (1) | NZ599097A (en) |
RU (1) | RU2012113418A (en) |
TN (1) | TN2012000151A1 (en) |
TW (1) | TW201118168A (en) |
WO (1) | WO2011042534A1 (en) |
ZA (1) | ZA201202291B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2013125221A1 (en) * | 2012-02-21 | 2015-07-30 | 静岡県 | Affinity ligand for antibody purification |
JP6386995B2 (en) * | 2013-04-08 | 2018-09-05 | テオリアサイエンス株式会社 | Colorectal cancer detection method |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4424200A (en) | 1979-05-14 | 1984-01-03 | Nuc Med Inc. | Method for radiolabeling proteins with technetium-99m |
US4479930A (en) | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
US4831175A (en) | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
GB8924581D0 (en) | 1989-11-01 | 1989-12-20 | Pa Consulting Services | Bleaching of hair |
GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
JPH05244982A (en) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | Humanized b-b10 |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
US6245898B1 (en) * | 1998-06-15 | 2001-06-12 | The Research Foundation Of State University Of New York | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
US8227576B2 (en) * | 2006-03-30 | 2012-07-24 | Glaxo Group Limited | Antibodies against amyloid-β peptide |
AU2007285217B2 (en) * | 2006-08-14 | 2013-02-07 | Forerunner Pharma Research Co., Ltd | Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies |
GB0619291D0 (en) * | 2006-09-29 | 2006-11-08 | Ucb Sa | Altered antibodies |
FR2907341B1 (en) * | 2006-10-18 | 2012-08-17 | Pf Medicament | USE OF ANTI-CD151 ANTIBODY FOR THE TREATMENT OF CANCER |
CN104650235A (en) * | 2007-11-30 | 2015-05-27 | 葛兰素集团有限公司 | Antigen-Binding Constructs |
FR2929946B1 (en) * | 2008-04-11 | 2010-05-28 | Pf Medicament | NOVEL ANTI-CD151 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER |
-
2009
- 2009-10-09 EP EP09305964A patent/EP2308897A1/en not_active Withdrawn
-
2010
- 2010-10-07 TW TW099134185A patent/TW201118168A/en unknown
- 2010-10-08 RU RU2012113418/10A patent/RU2012113418A/en not_active Application Discontinuation
- 2010-10-08 CA CA2775634A patent/CA2775634A1/en not_active Abandoned
- 2010-10-08 NZ NZ599097A patent/NZ599097A/en not_active IP Right Cessation
- 2010-10-08 MX MX2012004059A patent/MX2012004059A/en unknown
- 2010-10-08 JP JP2012532613A patent/JP2013507114A/en active Pending
- 2010-10-08 AU AU2010305360A patent/AU2010305360A1/en not_active Abandoned
- 2010-10-08 CN CN2010800506032A patent/CN102597004A/en active Pending
- 2010-10-08 AR ARP100103678A patent/AR078572A1/en unknown
- 2010-10-08 KR KR1020127009804A patent/KR20120094474A/en not_active Application Discontinuation
- 2010-10-08 WO PCT/EP2010/065085 patent/WO2011042534A1/en active Application Filing
- 2010-10-08 BR BR112012008266A patent/BR112012008266A2/en not_active IP Right Cessation
- 2010-10-08 US US13/500,745 patent/US20120275997A1/en not_active Abandoned
- 2010-10-08 EP EP10771377A patent/EP2486057A1/en not_active Withdrawn
-
2012
- 2012-03-28 IN IN2696DEN2012 patent/IN2012DN02696A/en unknown
- 2012-03-29 ZA ZA2012/02291A patent/ZA201202291B/en unknown
- 2012-04-02 TN TNP2012000151A patent/TN2012000151A1/en unknown
- 2012-04-03 IL IL219034A patent/IL219034A0/en unknown
- 2012-04-13 MA MA34772A patent/MA33668B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2012113418A (en) | 2013-11-20 |
CN102597004A (en) | 2012-07-18 |
WO2011042534A1 (en) | 2011-04-14 |
TN2012000151A1 (en) | 2013-12-12 |
ZA201202291B (en) | 2012-11-28 |
BR112012008266A2 (en) | 2019-09-24 |
EP2486057A1 (en) | 2012-08-15 |
KR20120094474A (en) | 2012-08-24 |
CA2775634A1 (en) | 2011-04-14 |
MX2012004059A (en) | 2012-05-22 |
MA33668B1 (en) | 2012-10-01 |
US20120275997A1 (en) | 2012-11-01 |
JP2013507114A (en) | 2013-03-04 |
EP2308897A1 (en) | 2011-04-13 |
IN2012DN02696A (en) | 2015-09-04 |
TW201118168A (en) | 2011-06-01 |
AR078572A1 (en) | 2011-11-16 |
AU2010305360A1 (en) | 2012-04-19 |
IL219034A0 (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ616382A (en) | Antibodies specific to cadherin-17 | |
NZ592215A (en) | c-MET ANTIBODIES | |
NZ712765A (en) | Antibodies that bind csf1r | |
NZ600262A (en) | Anti-her3 antibodies and uses thereof | |
NZ700437A (en) | Anti-cmet antibody and its use for the detection and the diagnosis of cancer | |
GB2488091A (en) | Humanized anti-interleukin 3 receptor alpha chain antibodies | |
NZ702680A (en) | Anti-gd2 antibodies | |
NZ597664A (en) | Humanized anti-cdcp1 antibodies | |
NZ584658A (en) | Antibodies that bind il-4 and/or il-13 and their uses | |
MX2010002406A (en) | Combination therapy with type i and type ii anti-cd20 antibodies. | |
MX341958B (en) | Antibodies against human il33r and uses thereof. | |
MX2019014658A (en) | Humanized antibodies that recognize alpha-synuclein. | |
NZ594339A (en) | Anti-fgfr3 antibodies and methods using same | |
WO2013173496A3 (en) | Cd33 antibodies and use of same to treat cancer | |
NZ600022A (en) | Anti CD37 antibodies | |
NZ601584A (en) | Methods for treating colorectal cancer | |
NZ610976A (en) | Anti-mesothelin antibodies and immunoconjugates | |
MY159553A (en) | Detection and treatment of pancreatic, ovarian and other cancers | |
NZ586053A (en) | Anti-vegf antibody compositions and methods | |
NZ724971A (en) | Folate receptor 1 antibodies and immunoconjugates and uses thereof | |
NZ611785A (en) | Anti-notch1 antibodies | |
NZ599140A (en) | Antibodies that specifically bind to the epha2 receptor | |
NZ603607A (en) | Cgrp antibodies | |
TR201815254T4 (en) | ANTIBODIES CONNECTED TO TL1A AND THEIR USES | |
NZ618067A (en) | Anti-cd100 antibodies and methods for using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 OCT 2015 BY ACUMASS Effective date: 20140923 |
|
LAPS | Patent lapsed |